Molecular and genetic characterisation of contralateral breast cancer (CBC) and the identification of markers of CBC risk: opportunities for personalised surgery

Colin McIlmunn(Cancer Research UK), Stuart McIntosh(Queen's University Belfast), Jacqueline A. James(Queen's University Belfast), Kienan I. Savage(Queen's University Belfast), David González de Castro(Complejo Hospitalario de Salamanca), Deirdre Fitzpatrick(Queen's University Belfast)
Research Portal (Queen's University Belfast)
May 1, 2018
Cited by 0

Related Papers

QuPath: Open source software for digital pathology image analysis
|Scientific Reports|2017|8.9k
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
QuPath: Open source software for digital pathology image analysis
|bioRxiv (Cold Spring Harbor Laboratory)|2017|809
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
|The Lancet Oncology|2013|728
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis
|Nature Genetics|1999|496